GSA Capital Partners’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-85,419
Closed -$41K 1659
2020
Q4
$41K Buy
+85,419
New +$43.1K 0.01% 1141
2020
Q3
Sell
-22,972
Closed -$16K 1459
2020
Q2
$16K Buy
+22,972
New +$18.5K 0.01% 562
2018
Q2
Sell
-11,835
Closed -$18K 2040
2018
Q1
$18K Hold
11,835
﹤0.01% 1567
2017
Q4
$9K Sell
11,835
-175,541
-94% -$157K ﹤0.01% 1521
2017
Q3
$217K Buy
+187,376
New +$236K 0.01% 1418
2017
Q2
Sell
-30,144
Closed -$80K 2059
2017
Q1
$80K Buy
+30,144
New +$108K ﹤0.01% 1678
2016
Q4
Sell
-14,948
Closed -$40K 2046
2016
Q3
$40K Sell
14,948
-30,180
-67% -$69.4K ﹤0.01% 1728
2016
Q2
$80K Buy
+45,128
New +$92.1K ﹤0.01% 1686

Other funds holding GEN

GSA Capital Partners's GEN Position: Q1 2021 in Review

GSA Capital Partners sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 85,419 shares — an estimated $41K sold.

GSA Capital Partners first reported a position in GEN in Q2 2016 and held it in 8 quarters. The position peaked at $217K in Q3 2017. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • GSA Capital Partners reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • GSA Capital Partners sold 85,419 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $41K.
  • GSA Capital Partners first reported a position in Genesis Healthcare, Inc. in Q2 2016 and held it in 8 quarters.
  • GSA Capital Partners's Genesis Healthcare, Inc. position peaked at $217K in Q3 2017.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on GSA Capital Partners's 13F filing for Q1 2021, filed 10 May 2021.